Activation of toll-like receptor (22), interferon (23), and CD40 signaling pathways (24) promotes M1 macrophage differentiation, enhancing antigen presentation, directly phagocytosing tumor cells, and recruiting CD8+ T cells and NK cells (21). This evidence concerns the gene CD40 and neoplasm.